- $38.23m
- $21.63m
- $21.61m
- 96
- 92
- 41
- 90
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 22.7 | 23.4 | 26.3 | 21.6 | 21.6 |
Cost of Revenue | |||||
Gross Profit | 12.5 | 12.2 | 13.9 | 11.5 | 10.9 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 17.6 | 17.9 | 19.5 | 16 | 16.9 |
Operating Profit | 5.04 | 5.46 | 6.83 | 5.52 | 4.75 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 5.52 | 5.84 | 6.88 | 5.62 | 5.53 |
Provision for Income Taxes | |||||
Net Income After Taxes | 5.07 | 5.38 | 5.95 | 5.29 | 5.17 |
Net Income Before Extraordinary Items | |||||
Net Income | 5.07 | 5.38 | 5.95 | 5.29 | 5.17 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 5.07 | 5.38 | 5.95 | 5.29 | 5.17 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.254 | 0.267 | 0.296 | 0.259 | 0.252 |
Dividends per Share |